|
|
||||||||
Clinical Chemistry, Vol 21, 1878-1881, Copyright © 1975 by the American Association for Clinical Chemistry
1 Division of Biochemistry, Walter Reed Army Institute of Research, Washington, D. C. 20012.
A commercial radioimmunoassay kit was evaluated for
efficacy in detecting methaqualone or its metabolites in
urine of persons receiving this drug. The drug and its unconjugated 3'- and 4'-monohydroxy metabolites could
be detected equally well. The unconjugated
-monohydroxy metabolite was about 80% as reactive and the
unconjugated 6-monohydroxy metabolite reacted only
very weakly. Quantitation of the conjugated metabolites
was less sensitive than of unconjugated. Nineteen urine
specimens which reacted positively to radioimmunoassay and which thin-layer chromatography had shown to
contain methaqualone and its metabolites were also examined by gas-liquid chromatography. Those specimens that reacted strongly to radioimmunoassay contained high concentrations of the drug or its metabolites.
In the specimens examined by gas-liquid chromatography, the apparent concentrations of the metabolites
were generally higher than those of the drug itself.
Methaqualone in combination with its unconjugated metabolites reacted additively with the radioimmunoassay,
resembling the same concentration of parent drug
alone. Detection limits were between 10-200 µg/liter.
Submitted on June 16, 1975
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |